1[1]Shimaoka S,Akiyama S,Nishimata H.The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma[J].Cancer,2000,88(10):2220-2227.
2[2]Sakamoto H,Shirakawa T,Izuka S,et al.Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement[J].Gynecol Oncol,1999,72(3):298-305.
3[3]Fujiwaki R,Hata K,Iida K,et al.Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer[J].Gyne Onco,1998,68(3):247-252.
4[4]Van Triest B,Pinedo HM,Blaauwgeers JL,et al.Prognostic role of thymidylate synthase,thymidine phosphorylase/platelet-derived endometrial cell growth factor, and proliferation markers in colorectal cancer[J].Clin Cancer Res,2000,6(3):1063-1072.
5[5]Hata K,Fujiwaki R,Maede Y,et al.Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity[J].Gynecol Oncol,2000,77(1):26-34.
6[6]Arima J,Imazona,Takebayashi Y,et al.Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder[J].Cancer,2000,88(5):1131-1138.
7[7]Stevenson DP,Collins WP,Faraneh F,et al.Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: Implication for the treatment of ovarian cancer[J].Am J Path,1998,153(5):1573-1578.
8[8]Kato Y,Matsukawa S,Muraoka,et al.Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA[J].Br J Cancer,1997,75(4):506-511.
9[9]Stevenson DP,milligan SR,Collins WP.Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis[J].Am J Path,1998,152(6):1641-1646.
10[10]Fujimoto J,Ichigo S,Sakaguchi H,et al.Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers[J].Cancer Letters,1998,130(1):115-120.
5Hayashi S, MasudaH, Shigematsu M. Liver metastasis rare in colorectal cancer patients with fatty liver. Hepatogastroenterology, 1997, 44:1069 -1075.
6Iascone C, Ruperto M, Barillari P. Occurrence of synchronous coloreetal cancer metastasis in the cirrhotic or fatty liver. Minerva Chir, 2005, 60:185-190.
7Tamura R, Masuda H, Ishii Y, et al. Relationship between fatty liver and liver metastasis in ra~s given injection of rat colon cancer cell line. Hepatogastroenterology, 1999, 46: 167-171.
8Kohn EC. Invasion and metastasis: biology and clinical potential. Pharmaeol Ther, 1991,52 : 235-244.
9Kohn EC, Liotta LA. Invasion and metastasis: approaches to an old problem. Oncology (Williston Park), 1993,7:47-52, 57, 60 -62.
10Folkman J. Role of angiogenesis in tumor growth and metastasis. SeminOncol,2002,29(6 Suppl 16) :15- 18.
